Skip Navigation

Annals of Oncology 2006 17(8):1179; doi:10.1093/annonc/mdl293
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology

in this issue

in this issue

The first 10% of the full text of this article appears below.


   Extranuclear hormone receptors in primary breast cancer
 
Proliferation of breast cancer cells is divided into hormone-dependent and -independent tumor growth; the former is regulated by the expression of hormone receptors (HRs) such as estrogen (ER) and progesterone receptors (PR). Estrogens such as estradiol are a crucial growth factor for HR-positive breast cancer cells, with growth stimulation being mediated by the genomic action of nuclear ERs. In contrast, extranuclear ER expressed in the cell membrane and cytoplasm . . . [Full Text of this Article]


   Survival differences for bronchioloalveolar carcinoma patients
 

   Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth
 

   Colorectal cancer screening using sigmoidoscopy
 

   Quote
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?